Bill117th CongressFiled Nov 17, 2022Health
S. 6
Biosimilar Red Tape Elimination Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Nov 17, 2022)
Biosimilar Red Tape Elimination Act
This bill removes and otherwise modifies certain requirements related to the approval of biosimilars, such as prohibiting the Food and Drug Administration from requiring studies that assess the risks of switching between the biosimilar and the reference biologic.
What just happenedNov 17, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Lee, Mike [R-UT](R-UT)Sponsor
1committees2actions
- Introduced in SenateNov 17, 2022
- Nov 17, 2022IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Nov 17, 2022IntroReferral10000
Introduced in Senate